Indications and uses
■ temporarily relieves minor aches and pains ■ for other uses, see your doctor, but do not use for more than 10 days without consulting your doctor because serious side effects may occur
■ temporarily relieves minor aches and pains ■ for other uses, see your doctor, but do not use for more than 10 days without consulting your doctor because serious side effects may occur
■ drink a full glass of water with each dose ■ adults and children 12 years and over: take 4 to 8 tablets every 4 hours not to exceed 48 tablets in 24 hours unless directed by a doctor ■ children under 12 years: consult a doctor
Aspirin 81 mg (NSAID*)
*nonsteroidal anti-inflammatory drug
Pain reliever
In case of overdose, get medical help or contact a Poison Control Center right away. Keep out of reach of children.
■ temporarily relieves minor aches and pains
■ for other uses, see your doctor, but do not use for more than 10 days without consulting your doctor because serious side effects may occur
Children and teenagers who have or are recovering from chicken pox or flulike Reyeʼs syndrome:
symptoms should not use this product. When using this product, if changes in behavior with
nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of
Reye’s syndrome; a rare but serious illness.
Aspirin may cause a severe allergic reaction, which may include: Allergy alert:
■ hives ■ facial swelling ■ shock ■ asthma (wheezing)
This product contains an NSAID, which may cause severe stomach Stomach bleeding warning:
bleeding. The chance is higher if you: ■ are age 60 or older ■ have had stomach ulcers or bleeding
problems ■ take a blood thinning (anticoagulant) or steroid drug ■ take other drugs containing
prescription or nonprescription NSAIDs (aspirin, ibuprofen, naproxen, or others) ■ have 3 or more
alcoholic drinks every day while using this product ■ take more or for a longer time than directed
■ if you are allergic to aspirin or any other pain reliever/fever reducer Do not use
■ stomach bleeding warning applies to you Ask a doctor before use if
■ you have a history of stomach problems, such as heartburn ■ you have high blood pressure,
heart disease, liver cirrhosis, or kidney disease ■ you are taking a diuretic ■ you have asthma
■ you have not been drinking fluids ■ you have lost a lot of fluid due to vomiting or diarrhea
Ask a doctor or pharmacist before use if you are
■ taking a prescription drug for diabetes, gout, or arthritis
■ under a doctor’s care for any serious condition ■ taking any other drug
■ you experience any of the following signs of stomach bleeding: Stop use and ask a doctor if
■ feel faint ■ have bloody or black stools ■ vomit blood ■ have stomach pain that does not get better
■ pain gets worse or lasts more than 10 days ■ fever gets worse or lasts more than 3 days
■ redness or swelling is present in the painful area ■ any new symptoms appear
■ ringing in the ears or a loss of hearing occurs
, ask a health professional before use. It is especially important not If pregnant or breast-feeding
to use aspirin during the last 3 months of pregnancy unless definitely directed to do so by a doctor
because it may cause problems in the unborn child or complications during delivery.
■ drink a full glass of water with each dose
■ adults and children 12 years and over: take 4 to 8 tablets every 4 hours not to exceed 48 tablets in 24 hours unless directed by a doctor
■ children under 12 years: consult a doctor
anhydrous lactose, carnauba wax, colloidal silicon dioxide,
croscarmellose sodium, D&C yellow #10 aluminum lake, iron oxide ochre, methacrylic acid
copolymer, microcrystalline cellulose, polysorbate 80, simethicone, sodium hydroxide, sodium
lauryl sulfate, talc, titanium dioxide, triethyl citrate
Adverse Drug Event Call: (800) 616-2471
■ store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)
■ use by expiration date on package
**Compare to the active ingredient in Low Dose BAYER®
**This product is not manufactured or distributed by Bayer HealthCare LLC, owner of the registered
trademark Bayer® Low Dose.
Distributed by
Major Pharmaceuticals
31778 Enterprise Drive,
Livonia, MI 48150 USA
ASPIR LOW™
LOW STRENGTH 81mg ASPIRIN (NSAID)
Enteric Coated
1 1/4 gr. (81 mg) each Analgesic
SEE NEWWARNINGSINFORMATION
NEWTabletAppearance
THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
MAJOR®
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1293665 | Aspir Low 81 MG Delayed Release Oral Tablet | PSN | 2 |
| 308416 | aspirin 81 MG Delayed Release Oral Tablet | PSN | 2 |
| 1293665 | aspirin 81 MG Delayed Release Oral Tablet [Aspir-Low] | SBD | 2 |
| 308416 | aspirin 81 MG Delayed Release Oral Tablet | SCD | 2 |
| 308416 | ASA 81 MG Delayed Release Oral Tablet | SY | 2 |
| 1293665 | ASA 81 MG Delayed Release Oral Tablet [Aspir-Low] | SY | 2 |
| 1293665 | Aspir-Low 81 MG Delayed Release Oral Tablet | SY | 2 |
| 308416 | aspirin 81 MG Enteric Coated Oral Tablet | SY | 2 |
| Class | Version | Type | Effective |
|---|---|---|---|
| ASPIRIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50436-0128-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-f79d-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50436-0128-1 | Aspir Low | 30 in 1 BOTTLE | TABLET | 30 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50436-0128 | ASPIR LOW (ASPIRIN) TABLET [UNIT DOSE SERVICES] | 2 | Legacy NDC, 1 package rows | 20140328_50c157d7-ea12-4a55-82ba-4190bd1fd4c5.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | 2 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | 2 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 2 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | 2 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50436-0128 | 50436-0128-1 |
| 49483-390 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ANHYDROUS LACTOSE | ANHYDROUS LACTOSE | 3SY5LH9PMK | TABLET / ORAL | 6795 mg | ||
| D&C YELLOW NO. 10 | D&C YELLOW NO. 10 | 35SW5USQ3G | TABLET / ORAL | 80 mg | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET / ORAL | 10 mg | ||
| TRIETHYL CITRATE | TRIETHYL CITRATE | 8Z96QXD6UM | TABLET / ORAL | 52 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET / ORAL | 736 mg | ||
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | NX76LV5T8J | TABLET / ORAL | 489 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| CARNAUBA WAX | CARNAUBA WAX | R12CBM0EIZ | TABLET / ORAL | 167.8 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / ORAL | 24 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| aspirin low dose enteric coated | ASPIRIN | Time-Cap Labs, Inc | 7146c505-2469-4bc2-9e1e-ceb60951c8ae | 2018-12-17 | Warnings | 49483-390 |
| 3afa1966-3613-4e1b-b9ab-5b2712df183e | 50c157d7-ea12-4a55-82ba-4190bd1fd4c5 | 2012-08-02 | Warnings | 3afa1966-3613-4e1b-b9ab-5b2712df183e 50c157d7-ea12-4a55-82ba-4190bd1fd4c5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.